Amatuximab Antibody

SKU: orb1980770

Description

Amatuximab (MORab-009) is a humanized chimeric monoclonal antibody targeting mesothelin (MSLN) on cancer cells. It exhibits antitumor activity and has been investigated in preclinical and clinical studies for mesothelin-expressing solid tumors, such as mesothelioma and pancreatic cancer.

Research Area

Immunology & Inflammation

Images & Validation

−

Key Properties

−

CAS Number	931402-35-6
MW	144.31 kDa
Purity	95.2% (SDS-PAGE); 98.4% (SEC-HPLC)
Target	Mesothelin,Others

Bioactivity

−

In Vivo	In tumor xenograft studies, the combination treatment of Amatuximab and chemotherapy significantly reduces the growth of mesothelin-expressing tumors to a greater extent compared to the use of Amatuximab or chemotherapy alone. Read more...
In Vitro	Amatuximab (MORAb-009) is a murine-human chimeric monoclonal antibody with selective affinity for mesothelin (MSLN). In vitro, Amatuximab can induce antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cell lines expressing mesothelin and inhibit heterotypic cell adhesion between mesothelin-positive tumor cells and tumor cells expressing CA125. Read more...

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

MORab-009, Amatuximab

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

Mesothelin,Others

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols